Mergers & Acquisitions - Mergers & Acquisitions, Antibiotics and Infectious diseases


Popular Filters

FTC approves final order on Akorn divestment in bid for VersaPharm

FTC approves final order on Akorn divestment in bid for VersaPharm


Following a public comment period, the US Federal Trade Commission has approved a final order settling…

AkornAntibiotics and Infectious diseasesGenericsLegalMergers & AcquisitionsRifampinUSAVersaPharm

FTC puts conditions on Akorn’s proposed acquisition of VersaPharm

FTC puts conditions on Akorn’s proposed acquisition of VersaPharm


The US Federal Trade Commission revealed yesterday that US generics drugmaker Akorn has agreed to sell…

AkornAntibiotics and Infectious diseasesClinical researchGeneric injectable tuberculosisGenericsMergers & AcquisitionsRegulationRifampinUSAVersaPharm

ANI Pharma acquires Vancocin assets from Shire

ANI Pharma acquires Vancocin assets from Shire


US generic drugmaker ANI Pharmaceuticals says it has acquired the US rights for the antibiotic Vancocin…

ANI PharmaceuticalsAntibiotics and Infectious diseasesEli Lilly and CompanyGenericsGlycopeptide antibioticsIrelandMergers & AcquisitionsNew DrugShireUSAVancocinVancomycin HCl

Transcept and Paratek join forces in reverse takeover

Transcept and Paratek join forces in reverse takeover


US pharma company Transcept Pharmaceuticals and privately-held biopharmaceutical company Paratek Pharmaceuticals…

Antibiotics and Infectious diseasesMergers & AcquisitionsParatek PharmaceuticalsPharmaceuticalTranscept PharmaUSA

Evotec to acquire Euprotec to establish an anti-infectives platform

Evotec to acquire Euprotec to establish an anti-infectives platform


Germany’s Evotec says it has acquired all the shares in Euprotec Ltd, a UK-based specialist contract…

Anti-infective drug discovery servicesAntibiotics and Infectious diseasesBusiness FinanceDiseaseEvotecHealth Medical PharmaMergers & AcquisitionsPharmaceuticalRecognised leader

Debiopharm to acquire Affinium's antibiotic clinical assets and platform


Swiss drug developer Debiopharm Group has entered into an agreement to acquire Canadian venture capital…

Affinium PharmaceuticalsAFN-1720Antibiotics and Infectious diseasesDebiopharmMergers & AcquisitionsPharmaceutical

Astellas partners with ClearPath to build vaccine portfolio; sells fermentation assets

Astellas partners with ClearPath to build vaccine portfolio; sells fermentation assets


Japanese drug major Astellas Pharma has entered into a strategic partnership with ClearPath Development…

Antibiotics and Infectious diseasesAstellas PharmaClearPath DevelopmentLicensingMergers & AcquisitionsMymetics CorpOtsukaPharmaceuticalRSV CorpTaiho Pharmaceutical

The Medicines Company acquires antibiotics maker Rempex Pharma


USA-based The Medicines Company has acquired Rempex Pharmaceuticals, a company with multiple potential…

Antibiotics and Infectious diseasesMergers & AcquisitionsPharmaceuticalRempex PharmaceuticalsThe Medicines Company

Cubist Pharma signs two acquisition deals in one day


In what must have been a busy day for US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) announced not…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMergers & AcquisitionsOptimer PharmaceuticalsPharmaceuticaltedizolidTrius Therapeutics

Terms amended in Bellus' acquisition of Thallion


Canada-based drugmaker Bellus Health (TSX: BLU) has amended its agreement to acquire fellow Canadian…

Antibiotics and Infectious diseasesBellus HealthBiotechnologyMergers & AcquisitionsNorth AmericaShigamabsThallion Pharmaceuticals

Briefs: Boehringer files Pradaxa for DVT and PE; Astellas' Mycamine pediatric approval; Simcere divests Boda


Family-owned German drug major Boehringer Ingelheim has submitted an application to the European Medicines…

Antibiotics and Infectious diseasesAstellas PharmaBoehringer IngelheimCardio-vascularEuropeJilin BodaMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationSimcere PharmaceuticalYidashen

Grifols gains global rights to Aradigm's Pulmaquin


Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

Novo A/S acquires Norway's Xellia Pharmaceuticals in $700 million deal


Denmark-based Novo A/S, the holding company of the Novo Group and the major shareholder in Novo Nordisk…

Antibiotics and Infectious diseasesGenericsMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalXellia Pharmaceuticals

DCC Healthcare acquires generic drugmaker Kent Pharma


Dublin, Ireland-based sales, marketing, distribution and business support services group DCC, says that…

Antibiotics and Infectious diseasesDCC HealthcareGenericsKent PharmaceuticalMergers & Acquisitions

Synthetic Biologics to acquire clinical-stage C. diff infectious disease program


USA-based Synthetic Biologics (NYSE: SYN), a developer of synthetic biologics and innovative medicines…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsPrev AbRSYN-004Synthetic Biologics

MicuRx joins forces with VC for next-generation antibiotic for China


MicuRx Pharmaceuticals, a privately-held US biopharmaceutical company developing next-generation antibiotics,…

Antibiotics and Infectious diseasesAsia-PacificMergers & AcquisitionsMicuRx PharmaceuticalsMRX-IPharmaceuticalResearchShanghai MengKe Pharma

Forest acquires rights to Nabriva antibacterial and option to buy firm


US drugmaker Forest Laboratories (NYSE: FRX) says it has entered into an agreement with Austrian biotech…

Antibiotics and Infectious diseasesBC-3781BiotechnologyForest LaboratoriesLicensingMergers & AcquisitionsNabriva TherapeuticsPharmaceutical

News briefs: GlaxoSmithKline and Bayer


UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Teva settles Nuvigil patent litigation with Mylan, which debuts generic Doryx


Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said…

Antibiotics and Infectious diseasesDoryxGenericsLegalMergers & AcquisitionsMylan LaboratoriesNeurologicalNorth AmericaNuvigilPatentsPharmaceuticalTeva Pharmaceutical IndustriesWarner Chilcott

Zydus Cadila acquires Mumbai-based Biochem


Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top…

Antibiotics and Infectious diseasesAsia-PacificBiochemGenericsMergers & AcquisitionsZydus Cadila



Back to top